Key Risk Factors Affecting Treatment Choice in Melanoma
West provider, Dr. G. Gary Tian, joins Dr. Evan J. Lipson with John Hopkins Medicine and other oncology experts to discuss critical factors influencing physicians’ decisions between monotherapy and doublet therapy for Metastatic Melanoma.
The group dives into the latest treatment options for metastatic melanoma, their efficacy, and potential risks.